drugset / Trial / NCT00511212

Intravenous Immunoglobulin in Combination Therapy With Antibacterial Agents for SSI of the Lower Digestive Tract

NCT00511212

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the clinical usefulness of IVIG in combination therapy with antibacterial agents for severe peritonitis after lower digestive tract surgery.

Timeline

Start
2007-08
Primary completion
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Immune Globulin Intravenous (Human) Protein / enzyme biologic Intravenous

Indications